{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE g.symbol = 'PSMA1' OR any(s IN coalesce(g.synonyms, []) WHERE s = 'PSMA1')\nRETURN v.name AS variant_name\nLIMIT 100", "error": null, "latency_ms": 1813.50139999995, "input_tokens": 5048, "output_tokens": 54, "gold_rows": [], "generated_rows": [], "id": "F1.4-000157-P4", "question": "Enumerate the variants linked to PSMA1.", "gold_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PSMA1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PSMA1'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "instructions": "- Match (v:Variant)-[:VARIANT_OF]->(g:Gene) where g.symbol = 'PSMA1' or any(s IN coalesce(g.synonyms, []) WHERE s = 'PSMA1').\n- Return variant_name."}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('MT-ND6') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('MT-ND6'))\nRETURN b.name AS variant_name\nLIMIT 100", "error": null, "latency_ms": 560.3223000071011, "input_tokens": 5045, "output_tokens": 66, "gold_rows": [], "generated_rows": [], "id": "F1.4-000057-P1", "question": "What variants are known for the MT-ND6 gene?", "gold_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('MT-ND6')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('MT-ND6'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "instructions": "- Match (b:Variant)-[:VARIANT_OF]->(g:Gene) where g.symbol = 'MT-ND6' or any synonym of g.symbol equals 'MT-ND6'.\n- Return variant_name."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE g.symbol = 'RRM1' OR any(s IN coalesce(g.synonyms, []) WHERE s = 'RRM1')\nRETURN\n  coalesce(b.name, b.hgvs_p) AS variant_name,\n  g.symbol AS gene_symbol,\n  NULL AS therapy_name,\n  NULL AS effect,\n  NULL AS disease_name,\n  [] AS pmids\nLIMIT 100", "error": null, "latency_ms": 531.5401999978349, "input_tokens": 5081, "output_tokens": 94, "gold_rows": [{"variant_name": "RRM1 Overexpression", "gene_symbol": "RRM1"}, {"variant_name": "RRM1 Underexpression", "gene_symbol": "RRM1"}], "generated_rows": [{"variant_name": "RRM1 Overexpression", "gene_symbol": "RRM1", "therapy_name": null, "effect": null, "disease_name": null, "pmids": []}, {"variant_name": "RRM1 Underexpression", "gene_symbol": "RRM1", "therapy_name": null, "effect": null, "disease_name": null, "pmids": []}], "id": "F1.4-000105-P1", "question": "What variants are known for the RRM1 gene?", "gold_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('RRM1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('RRM1'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "instructions": "- Match (b:Variant)-[:VARIANT_OF]->(g:Gene) where g.symbol = 'RRM1' or any(s IN coalesce(g.synonyms, []) WHERE s = 'RRM1').\n- Return variant_name (coalesce(b.name, b.hgvs_p)), gene_symbol, therapy_name = NULL, effect = NULL, disease_name = NULL, and pmids = []."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('melanoma')\nAND (\n  toLower(t.name) = toLower('Anti-CTLA-4 Monoclonal Antibody')\n  OR toLower(t.name) = toLower('RO4987655')\n  OR any(s IN coalesce(t.synonyms, [])\n         WHERE toLower(s) = toLower('Anti-CTLA-4 Monoclonal Antibody'))\n  OR any(s IN coalesce(t.synonyms, [])\n         WHERE toLower(s) = toLower('RO4987655'))\n  OR toLower(t.name) CONTAINS toLower('Anti-CTLA-4 Monoclonal Antibody')\n  OR toLower(t.name) CONTAINS toLower('RO4987655')\n)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, disease_name, collect(pmids) AS pmid_lists\nWITH gene_symbol, therapy_name, disease_name,\n     reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 1049.1924999514595, "input_tokens": 5169, "output_tokens": 354, "gold_rows": [{"variant_name": null, "gene_symbol": "CTNNB1", "therapy_name": "Anti-CTLA-4 Monoclonal Antibody", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["25970248"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "MEK Inhibitor RO4987655", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24947927"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "MEK Inhibitor RO4987655", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24947927"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "CTNNB1", "therapy_name": "Anti-CTLA-4 Monoclonal Antibody", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["25970248"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "MEK Inhibitor RO4987655", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24947927", "24947927"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "MEK Inhibitor RO4987655", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24947927"]}], "id": "F6.1-000138-S1-P3", "question": "What genes are resistance biomarkers for Anti-CTLA-4 Monoclonal Antibody or MEK Inhibitor RO4987655 in Malignant Melanoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Anti-CTLA-4 Monoclonal Antibody')\n  OR toLower(t.name) = toLower('MEK Inhibitor RO4987655')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Anti-CTLA-4 Monoclonal Antibody'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MEK Inhibitor RO4987655'))\n  OR toLower(t.name) CONTAINS toLower('Anti-CTLA-4 Monoclonal Antibody')\n  OR toLower(t.name) CONTAINS toLower('MEK Inhibitor RO4987655')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where rel.effect is 'resistance' and rel.disease_name contains 'melanoma'.\n- Match therapies by name: `t.name` = 'Anti-CTLA-4 Monoclonal Antibody' OR `t.name` = 'RO4987655' OR synonyms/CONTAINS fallbacks.\n- Match (b:Gene) OR (b:Variant)-[:VARIANT_OF]->(g:Gene).\n- Return gene_symbol only (set variant_name to NULL).\n- De-duplicate by gene_symbol, therapy_name, and disease_name.\n- Aggregate pmids across evidence rows."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Luminespib')\n    OR toLower(t.name) = toLower('Gefitinib')\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Luminespib'))\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Gefitinib'))\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('non-small cell lung')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, disease_name, collect(pmids) AS pmid_lists\nWITH gene_symbol, therapy_name, disease_name,\n     reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    'resistance' AS effect,\n    disease_name,\n    pmids\nLIMIT 100", "error": null, "latency_ms": 762.7355000004172, "input_tokens": 5161, "output_tokens": 293, "gold_rows": [{"variant_name": null, "gene_symbol": "CRKL", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22586683"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664", "25948633", "15728811", "17020982", "15737014", "19692680"]}, {"variant_name": null, "gene_symbol": "GNAS", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24758907"]}, {"variant_name": null, "gene_symbol": "IGF1R", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23619944"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15696205", "21258250"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17463250"]}, {"variant_name": null, "gene_symbol": "NRG1", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26418897"]}, {"variant_name": null, "gene_symbol": "PBK", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26745678"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21258250"]}, {"variant_name": null, "gene_symbol": "SMO", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26124204"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Luminespib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}], "generated_rows": [], "id": "F6.1-000045-S1-P3", "question": "What genes are resistance biomarkers for Luminespib or Gefitinib in Non-small Cell Lung Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Luminespib')\n  OR toLower(t.name) = toLower('Gefitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Luminespib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Gefitinib'))\n  OR toLower(t.name) CONTAINS toLower('Luminespib')\n  OR toLower(t.name) CONTAINS toLower('Gefitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where t.name is 'Luminespib' or 'Gefitinib' (case-insensitive) or a synonym of either.\n- Filter rel by toLower(rel.effect) = 'resistance'.\n- Filter rel.disease_name by CONTAINS 'non-small cell lung' (case-insensitive).\n- Match (b:Gene) OR (b:Variant)-[:VARIANT_OF]->(g:Gene).\n- Return gene_symbol, therapy_name, effect, disease_name, and aggregate pmids from rel.pmids. Set variant_name to NULL.\n- De-duplicate results by gene_symbol, therapy_name, and disease_name."}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Durvalumab')\n    OR toLower(t.name) = toLower('Vandetanib')\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Durvalumab'))\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Vandetanib'))\n    OR toLower(t.name) CONTAINS toLower('Durvalumab')\n    OR toLower(t.name) CONTAINS toLower('Vandetanib')\n  )\n  AND toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, disease_name, collect(pmids) AS pmid_lists\nWITH gene_symbol, therapy_name, disease_name,\n     reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 1196.9457999803126, "input_tokens": 5162, "output_tokens": 328, "gold_rows": [{"variant_name": null, "gene_symbol": "CD274", "therapy_name": "Durvalumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30872362"]}, {"variant_name": null, "gene_symbol": "BCL2L11", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22426421"]}, {"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Vandetanib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27496134"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "CD274", "therapy_name": "Durvalumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30872362"]}, {"variant_name": null, "gene_symbol": "BCL2L11", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22426421"]}, {"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Vandetanib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27496134"]}], "id": "F6.1-000018-S2-P2", "question": "List resistance genes for Durvalumab or Vandetanib in Non-small Cell Lung Carcinoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Durvalumab')\n  OR toLower(t.name) = toLower('Vandetanib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Durvalumab'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vandetanib'))\n  OR toLower(t.name) CONTAINS toLower('Durvalumab')\n  OR toLower(t.name) CONTAINS toLower('Vandetanib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where t.name is 'Durvalumab' or 'Vandetanib' (or synonyms/CONTAINS).\n- Filter by toLower(rel.effect) = 'resistance'.\n- Filter by toLower(rel.disease_name) CONTAINS 'lung' for Non-small Cell Lung Carcinoma.\n- Match biomarker as (b:Gene) OR (b:Variant)-[:VARIANT_OF]->(g:Gene).\n- Return gene_symbol, therapy_name, effect, disease_name, pmids; set variant_name to NULL.\n- De-duplicate by gene_symbol, therapy_name, disease_name and aggregate pmids across evidence rows."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = toLower('resistance')\nAND toLower(rel.disease_name) CONTAINS toLower('breast')\nAND (\n  toLower(t.name) = toLower('Hormone Therapy')\n  OR toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, [])\n         WHERE toLower(s) = toLower('Hormone Therapy'))\n  OR any(s IN coalesce(t.synonyms, [])\n         WHERE toLower(s) = toLower('Pictilisib'))\n)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, disease_name, collect(pmids) AS pmid_lists\nWITH gene_symbol, therapy_name, disease_name,\n     reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 718.1755999918096, "input_tokens": 5160, "output_tokens": 293, "gold_rows": [{"variant_name": null, "gene_symbol": "ESR1", "therapy_name": "Hormone Therapy", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["24185512"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Pictilisib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ESR1", "therapy_name": "Hormone Therapy", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["24185512", "24185512", "24185512", "24185512", "24185512"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Pictilisib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "id": "F6.1-000170-P1", "question": "In Breast Cancer, which genes confer resistance to Hormone Therapy or Pictilisib?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Hormone Therapy')\n  OR toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Hormone Therapy'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Hormone Therapy')\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where rel.disease_name contains 'breast'.\n- Match biomarker as (b:Gene) OR (b:Variant)-[:VARIANT_OF]->(g:Gene).\n- Filter for therapies where t.name is 'Hormone Therapy' OR t.name is 'Pictilisib' OR synonyms contain 'Hormone Therapy' OR synonyms contain 'Pictilisib'.\n- Filter for resistance effect: toLower(rel.effect) = 'resistance'.\n- Return gene_symbol, therapy_name, effect, disease_name, and aggregate pmids. Set variant_name to NULL.\n- De-duplicate by gene_symbol, therapy_name, and disease_name."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('PD98059')\n  OR toLower(t.name) = toLower('FOLFOX-4 Regimen')\n  OR any(s IN coalesce(t.synonyms, [])\n         WHERE toLower(s) = toLower('PD98059'))\n  OR any(s IN coalesce(t.synonyms, [])\n         WHERE toLower(s) = toLower('FOLFOX-4 Regimen'))\n  OR toLower(t.name) CONTAINS toLower('PD98059')\n  OR toLower(t.name) CONTAINS toLower('FOLFOX-4 Regimen')\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('colorectal')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, disease_name, collect(pmids) AS pmid_lists\nWITH gene_symbol, therapy_name, disease_name,\n     reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 1062.182900030166, "input_tokens": 5163, "output_tokens": 336, "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "FOLFOX-4 Regimen", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25666295"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "FOLFOX-4 Regimen", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25666295"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "PD98059", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["30448735"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "FOLFOX-4 Regimen", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25666295"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "FOLFOX-4 Regimen", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25666295"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "PD98059", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["30448735", "30448735"]}], "id": "F6.1-000059-P3", "question": "What genes are resistance biomarkers for PD98059 or FOLFOX-4 Regimen in Colorectal Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('PD98059')\n  OR toLower(t.name) = toLower('FOLFOX-4 Regimen')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('PD98059'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('FOLFOX-4 Regimen'))\n  OR toLower(t.name) CONTAINS toLower('PD98059')\n  OR toLower(t.name) CONTAINS toLower('FOLFOX-4 Regimen')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where t.name is 'PD98059' or t.name is 'FOLFOX-4 Regimen' (or synonyms/CONTAINS fallbacks).\n- Filter by toLower(rel.effect) = 'resistance'.\n- Filter by toLower(rel.disease_name) CONTAINS toLower('colorectal').\n- Match (b:Gene) OR (b:Variant)-[:VARIANT_OF]->(g:Gene).\n- Return gene_symbol, therapy_name, disease_name, pmids; set variant_name to NULL.\n- De-duplicate by gene_symbol, therapy_name, disease_name; aggregate pmids across evidence rows."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE NOT t.name = 'HDAC1'\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nOPTIONAL MATCH (t)-[:TARGETS]->(g:Gene)\nWHERE g.symbol = 'TOP1' OR 'TOP1' IN g.synonyms\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g2:Gene)\nRETURN\nCASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\nCASE WHEN b:Gene THEN b.symbol ELSE g2.symbol END AS gene_symbol,\nt.name AS therapy_name,\nrel.effect AS effect,\nrel.disease_name AS disease_name,\ncoalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 1144.5182000170462, "input_tokens": 5118, "output_tokens": 171, "gold_rows": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Datopotamab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["39250535"]}, {"variant_name": "ERBB2 A775_G776insTVMA", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 A775_G776insV", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 A775_G776insVVMA", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 Exon 20 Insertion", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34534430"]}, {"variant_name": "ERBB2 G776_V777delinsVCD", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G776delinsCV", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G776delinsLC", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G776delinsVC", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G778_P780dup", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G778_S779insLPS", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755A", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755M", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755P", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755S", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755W", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 Mutation", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 S310F", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 S310Y", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 Y772_A775DUP", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}], "generated_rows": [{"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "2,4-pyrimidinediamine", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18593892"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "ALK Inhibitor TAE684", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18594010"]}, {"variant_name": "ROS1 L2155S AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "ALK Inhibitor TAE684", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "AMG511", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31666701"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "ARS-1620", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29373830"]}, {"variant_name": "MET Exon 14 Skipping Mutation OR MET Overexpression", "gene_symbol": "MET", "therapy_name": "AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37041472"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "AZD3463", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "KRAS A146V", "gene_symbol": "KRAS", "therapy_name": "Abemaciclib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24836576"]}, {"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "Abemaciclib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27217383"]}, {"variant_name": "SMARCA4 Loss", "gene_symbol": "SMARCA4", "therapy_name": "Abemaciclib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30718506"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Adagrasib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37703579"]}, {"variant_name": "TP53 Deleterious Mutation", "gene_symbol": "TP53", "therapy_name": "Adjuvant Chemotherapy", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26899019"]}, {"variant_name": "TP53 Wildtype", "gene_symbol": "TP53", "therapy_name": "Adjuvant Chemotherapy", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26899019"]}, {"variant_name": "ERBB2 Amplification OR ERBB2 A775_G776insIVMA OR ERBB2 A775_G776insYVMA  OR ERBB2 G778_P780dup OR ERBB2 G778-779 insCPG OR ERBB2 G776_V777>VCV OR ERBB2 G776delinsVC OR ERBB2 L755P OR ERBB2 V659E OR ERBB2 S310F OR ERBB2 S335C", "gene_symbol": "ERBB2", "therapy_name": "Ado-trastuzumab Emtansine Regimen", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29989854"]}, {"variant_name": "EGFR A763_Y764insFQEA", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR E746V", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR E746_A750del", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960", "24353160"]}, {"variant_name": "EGFR E746_S752delinsD", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR E746_T751>I", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR E746_T751delinsVA", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22452896"]}, {"variant_name": "EGFR EGFR::RAD51 Fusion", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["27102076"]}, {"variant_name": "EGFR EGFR::RAD51 e24::e4", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["29472054"]}, {"variant_name": "EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23982599", "34298851", "26515464"]}, {"variant_name": "EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["25589191", "22452895"]}, {"variant_name": "EGFR Exon 19 Deletion AND MET Exon 14 Skipping Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["30341016"]}, {"variant_name": "EGFR Exon 20 Insertion", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["26051236"]}, {"variant_name": "EGFR G719", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22452895"]}, {"variant_name": "EGFR G719A AND MET Splice Site (c.2888-21_2888-20delinsGC)", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["30922580"]}, {"variant_name": "EGFR L718Q AND EGFR L718V", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L747_A750delinsP", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR L747_P753>Q", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR L747_P753delinsS", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960", "24353160"]}, {"variant_name": "EGFR L747_S752del", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR L747_T751delLREAT", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR L747_T751delinsP", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR L747_T751delinsQ", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23816960"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23982599", "34298851", "22452896", "18408761"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["24439929", "22452895"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22452896"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR S768I OR EGFR G719A OR EGFR L861Q", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22452895"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21732342"]}, {"variant_name": "ERBB2 A775_G776insYVMA", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30825613", "30096481"]}, {"variant_name": "ERBB2 Activating Mutation", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30096481"]}, {"variant_name": "ERBB2 G776L", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["22325357"]}, {"variant_name": "ERBB2 G778_P780dup", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["22325357"]}, {"variant_name": "ERBB2 Kinase Domain Mutation", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["22325357"]}, {"variant_name": "ERBB2 Y772_A775DUP", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["26559459", "22325357"]}, {"variant_name": "ERBB2 Y772_A775DUP", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Carcinoma", "pmids": ["19122144"]}, {"variant_name": "ERBB2 Y772_A775DUP", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19122144"]}, {"variant_name": "ERBB3 V855A", "gene_symbol": "ERBB3", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26689995"]}, {"variant_name": "KIF5B KIF5B::EGFR Fusion", "gene_symbol": "KIF5B", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["32903808"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31666701"]}, {"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24685132"]}, {"variant_name": "NRG1 Expression", "gene_symbol": "NRG1", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26418897"]}, {"variant_name": "SDC4 SDC4::NRG1 Fusion", "gene_symbol": "SDC4", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["28950338"]}, {"variant_name": "SLC3A2 SLC3A2::NRG1 Fusion", "gene_symbol": "SLC3A2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["28502724"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Alvespimycin", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22912387"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Alvespimycin", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22912387"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Alvespimycin", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22912387"]}, {"variant_name": "EGFR Exon 20 Insertion", "gene_symbol": "EGFR", "therapy_name": "Amivantamab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37870976"]}, {"variant_name": "EGFR L858R OR EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Amivantamab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37879444"]}, {"variant_name": "NQO1 EXPRESSION", "gene_symbol": "NQO1", "therapy_name": "Amrubicin", "effect": "resistance", "disease_name": "Lung Cancer", "pmids": ["21964527"]}, {"variant_name": "NQO1 P187S", "gene_symbol": "NQO1", "therapy_name": "Amrubicin", "effect": "sensitivity", "disease_name": "Lung Cancer", "pmids": ["21964527"]}, {"variant_name": "B2M High Expression", "gene_symbol": "B2M", "therapy_name": "Anti-PD-L1 Monoclonal Antibody", "effect": "sensitivity", "disease_name": "Lung Cancer", "pmids": ["34115389"]}, {"variant_name": "EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Anti-PD-L1 Monoclonal Antibody", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31086949"]}, {"variant_name": "EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Anti-PD1 Monoclonal Antibody", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31086949"]}, {"variant_name": "HAVCR2 Overexpression", "gene_symbol": "HAVCR2", "therapy_name": "Anti-TIM-3 Monoclonal Antibody", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26883990"]}, {"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26970723", "28472902", "30297397"]}, {"variant_name": "CD274 v242", "gene_symbol": "CD274", "therapy_name": "Atezolizumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30872362"]}, {"variant_name": "CTLA4 EXPRESSION", "gene_symbol": "CTLA4", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25428504"]}, {"variant_name": "CX3CL1 Underexpression", "gene_symbol": "CX3CL1", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25428504"]}, {"variant_name": "JAK3 S61C", "gene_symbol": "JAK3", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["26014096"]}, {"variant_name": "JAK3 V722I", "gene_symbol": "JAK3", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["26014096"]}, {"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28525386"]}, {"variant_name": "STK11 Mutation", "gene_symbol": "STK11", "therapy_name": "Atezolizumab", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["29773717"]}, {"variant_name": "EGFR EGFR::GNAT3 Fusion", "gene_symbol": "EGFR", "therapy_name": "Aumolertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["38595815"]}, {"variant_name": "EGFR EGFR::MACF1 Fusion", "gene_symbol": "EGFR", "therapy_name": "Aumolertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["38595815"]}, {"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Avelumab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26918451", "28472902"]}, {"variant_name": "CD274 v242", "gene_symbol": "CD274", "therapy_name": "Avelumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30872362"]}, {"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "B-Raf/VEGFR-2 Inhibitor RAF265", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25199829"]}, {"variant_name": "EGFR Alteration", "gene_symbol": "EGFR", "therapy_name": "BMVC-8C3O", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37481710"]}, {"variant_name": "EGFR Exon 18 Overexpression", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24039832"]}, {"variant_name": "KIF5B KIF5B::EGFR Fusion", "gene_symbol": "KIF5B", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["32903808"]}, {"variant_name": "GATA2 EXPRESSION", "gene_symbol": "GATA2", "therapy_name": "Bortezomib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["22541434"]}, {"variant_name": "ERBB2 Y772_A775DUP", "gene_symbol": "ERBB2", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27491651"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}], "id": "F6.2-000012-S1-P3", "question": "Show treatments for TOP1 excluding HDAC1 that have biomarker evidence in Non-small Cell Lung Cancer.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where t.name is not 'HDAC1'.\n- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol = 'TOP1' (or a synonym).\n- Filter by toLower(rel.disease_name) CONTAINS toLower('lung') for Non-small Cell Lung Cancer.\n- Return variant_name, gene_symbol, therapy_name, effect, disease_name, and rel.pmids."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE g.symbol = 'TOP1' AND NOT g.symbol = 'PTGS2'\nWITH t, r, g\nOPTIONAL MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('non-small')\nAND toLower(rel.disease_name) CONTAINS toLower('cell')\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nRETURN\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    r.moa AS targets_moa,\n    coalesce(r.ref_sources, []) AS ref_sources,\n    coalesce(r.ref_ids, []) AS ref_ids,\n    coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 604.1028999607079, "input_tokens": 5105, "output_tokens": 177, "gold_rows": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Datopotamab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["39250535"]}, {"variant_name": "ERBB2 A775_G776insTVMA", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 A775_G776insV", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 A775_G776insVVMA", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 Exon 20 Insertion", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34534430"]}, {"variant_name": "ERBB2 G776_V777delinsVCD", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G776delinsCV", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G776delinsLC", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G776delinsVC", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G778_P780dup", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 G778_S779insLPS", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755A", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755M", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755P", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755S", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 L755W", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 Mutation", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 S310F", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 S310Y", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}, {"variant_name": "ERBB2 Y772_A775DUP", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37694347"]}], "generated_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "id": "F6.2-000071-S1-P2", "question": "List therapies targeting TOP1 (not PTGS2) with evidence in Non-small Cell Lung Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PTGS2')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PTGS2'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[r:TARGETS]->(g:Gene) where g.symbol = 'TOP1' but NOT g.symbol = 'PTGS2'.\n- Filter for Non-small Cell Lung Carcinoma by requiring 'non-small', 'cell', and 'lung' (case-insensitive) to appear in rel.disease_name.\n- Return gene_symbol, therapy_name, targets_moa, ref_sources, ref_ids, and ref_urls."}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 2809.7685999819078, "input_tokens": 7251, "output_tokens": 180, "gold_rows": [{"gene_symbol": "HDAC8", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC8", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC8", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "HDAC8", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC8", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC8", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "id": "F3.2-000162-P1", "question": "Which drugs target both HDAC8 and HDAC9?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g1:Gene) where g1.symbol or synonyms match 'HDAC8' (case-insensitive).\n- Match (t)-[:TARGETS]->(g2:Gene) where g2.symbol or synonyms match 'HDAC9' (case-insensitive).\n- Return gene_symbol, therapy_name, r.moa AS targets_moa, r.ref_sources, r.ref_ids, r.ref_urls."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (t)-[:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('EML4')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('EML4'))\nRETURN t.name AS therapy_name\nLIMIT 100", "error": null, "latency_ms": 731.0376000241376, "input_tokens": 7228, "output_tokens": 119, "gold_rows": [{"gene_symbol": "ALK", "therapy_name": "Alectinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2015/208434s000lbl.pdf", "nda/2015/208434Orig1s000ClinPharmR.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Ceritinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2014/205755s000lbl.pdf", "label/2017/205755s009lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Crizotinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Lorlatinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK  inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2018/210868s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"]}], "generated_rows": [{"therapy_name": "Alectinib"}, {"therapy_name": "Ceritinib"}, {"therapy_name": "Crizotinib"}, {"therapy_name": "Lorlatinib"}], "id": "F3.2-000005-P1", "question": "Which drugs target both ALK and EML4?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('EML4')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('EML4'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g1:Gene) where g1.symbol or synonyms match 'ALK' (case-insensitive).\n- Match (t:Therapy)-[:TARGETS]->(g2:Gene) where g2.symbol or synonyms match 'EML4' (case-insensitive).\n- Return therapy_name."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('FGFR2')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR2'))\nWITH t, g, r\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('FGFR3')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('FGFR3'))\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 817.7045999909751, "input_tokens": 7255, "output_tokens": 186, "gold_rows": [{"gene_symbol": "FGFR2", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR2", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Lucitanib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://bit.ly/1ZGqyT3", "21212416", "22304225"], "ref_urls": ["http://bit.ly/1ZGqyT3", "http://europepmc.org/abstract/MED/21212416", "http://europepmc.org/abstract/MED/22304225"]}, {"gene_symbol": "FGFR2", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR2", "therapy_name": "TRK Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}, {"gene_symbol": "FGFR3", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Dovitinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR3", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pazopanib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR3", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}], "generated_rows": [{"gene_symbol": "FGFR2", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR2", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR2", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}], "id": "F3.1-000046-P3", "question": "Show treatments that target FGFR2 or FGFR3.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('FGFR2')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR2'))\n  OR toLower(g.symbol) = toLower('FGFR3')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR3'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or g.synonyms match 'FGFR2' (case-insensitive).\n- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or g.synonyms match 'FGFR3' (case-insensitive).\n- Return gene_symbol, therapy_name, r.moa AS targets_moa, r.ref_sources, r.ref_ids, and r.ref_urls."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = toLower('resistance')\nAND (\n  any(tag IN coalesce(t.tags, []) WHERE toLower(tag) CONTAINS toLower('platinum'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) CONTAINS toLower('platinum'))\n  OR toLower(t.name) CONTAINS toLower('platinum')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('ovarian')\nAND toLower(rel.disease_name) CONTAINS toLower('serous')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 878.9191000396386, "input_tokens": 7285, "output_tokens": 250, "gold_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "generated_rows": [{"variant_name": "AURKA Overexpression", "gene_symbol": "AURKA", "therapy_name": "Platinum Compound", "effect": "resistance", "disease_name": "Ovarian Serous Carcinoma", "pmids": ["27209210"]}], "id": "F4.2-000016-P2", "question": "Which drugs target biomarkers of resistance to Platinum Compound in Ovarian Serous Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where toLower(rel.effect) = 'resistance'.\n- Match Therapy by tags containing 'platinum' or synonyms containing 'platinum' or name containing 'platinum'.\n- Match Disease by tokens 'ovarian', 'serous', and 'carcinoma' in rel.disease_name.\n- OPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene).\n- Return variant_name, gene_symbol, therapy_name, effect, disease_name, and rel.pmids (default [])."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('imatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('imatinib'))\n  OR toLower(t.name) CONTAINS toLower('imatinib')\n)\nAND toLower(rel.effect) = toLower('resistance')\nAND toLower(rel.disease_name) CONTAINS toLower('melanoma')\nMATCH (t)-[:TARGETS]->(g:Gene)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 1266.2139000021853, "input_tokens": 7313, "output_tokens": 197, "gold_rows": [{"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Amuvatinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Avapritinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "C-Met Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Cediranib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Crenolanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://arogpharma.com/crenolanib", "22745105", "24623852"], "ref_urls": ["http://arogpharma.com/crenolanib", "http://europepmc.org/abstract/MED/22745105", "http://europepmc.org/abstract/MED/24623852"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Dovitinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Foretinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Linifanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["16648571", "17343372"], "ref_urls": ["http://europepmc.org/abstract/MED/16648571", "http://europepmc.org/abstract/MED/17343372"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Midostaurin", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Motesanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Nintedanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Pazopanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Quizartinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Ripretinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Sunitinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor | Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "TRK Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Vatalanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [{"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}], "id": "F4.2-000184-P3", "question": "Find therapies that target resistance genes for Imatinib in Melanoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Imatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Imatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Imatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where toLower(t.name) = toLower('imatinib') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('imatinib')) OR toLower(t.name) CONTAINS toLower('imatinib').\n- Filter rel by toLower(rel.effect) = toLower('resistance').\n- Filter rel.disease_name by tokens 'melanoma' (case-insensitive CONTAINS).\n- Match (t)-[:TARGETS]->(g:Gene) for the target gene of the therapy.\n- Return gene_symbol, therapy_name, effect, disease_name, and rel.pmids."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('dasatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('dasatinib'))\n  OR toLower(t.name) CONTAINS toLower('dasatinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('naevocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH b, rel, t,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower(gene_symbol)\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\nRETURN\n  g.symbol AS gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 728.4834999591112, "input_tokens": 7342, "output_tokens": 280, "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [], "id": "F4.2-000171-S1-P2", "question": "Which drugs target biomarkers of resistance to Dasatinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where toLower(t.name) = toLower('dasatinib') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('dasatinib')) OR toLower(t.name) CONTAINS toLower('dasatinib').\n- Filter by toLower(rel.effect) = 'resistance'.\n- Filter by toLower(rel.disease_name) CONTAINS toLower('naevocarcinoma').\n- Match (t2:Therapy)-[:TARGETS]->(g:Gene) where g.symbol is the gene associated with the biomarker.\n- Return gene_symbol, t2.name AS therapy_name, r.moa AS targets_moa, and reference arrays (r.ref_sources, r.ref_ids, r.ref_urls) if present."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('gemcitabine')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('gemcitabine'))\n    OR toLower(t.name) CONTAINS toLower('gemcitabine')\n  )\n  AND toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('pancreatic')\n  AND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nMATCH (t)-[:TARGETS]->(g:Gene)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 1159.1826000367291, "input_tokens": 7348, "output_tokens": 285, "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["24915778"]}, {"variant_name": null, "gene_symbol": "RB1", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["11792751"]}], "id": "F4.2-000042-P3", "question": "Find therapies that target resistance genes for Gemcitabine in Pancreatic Adenocarcinoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Gemcitabine')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine'))\n  OR toLower(t1.name) CONTAINS toLower('Gemcitabine')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Gemcitabine')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where toLower(t.name) = toLower('gemcitabine') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('gemcitabine')) OR toLower(t.name) CONTAINS toLower('gemcitabine').\n- Match rel.effect = 'resistance' (case-insensitive).\n- Match rel.disease_name CONTAINS toLower('pancreatic') AND rel.disease_name CONTAINS toLower('adenocarcinoma').\n- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g is the resistance gene. Consider gene synonyms using toLower().\n- Return gene_symbol, therapy_name, effect, disease_name, and pmids from rel.pmids (default to [] if absent)."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('imatinib')\n    OR toLower(t.name) CONTAINS toLower('imatinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('imatinib'))\n  )\n  AND toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('chronic')\n  AND toLower(rel.disease_name) CONTAINS toLower('myeloid')\n  AND toLower(rel.disease_name) CONTAINS toLower('leukemia')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 834.9242000258528, "input_tokens": 7315, "output_tokens": 244, "gold_rows": [{"gene_symbol": "ABL1", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["FDA", "Other", "Other"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf", "http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"], "ref_urls": ["http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Bafetinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16105974"], "ref_urls": ["http://europepmc.org/abstract/MED/16105974"]}, {"gene_symbol": "ABL1", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["BOSUTINIB", "label/2012/203341lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=BOSUTINIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "ABL1", "therapy_name": "Rebastinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21481795"], "ref_urls": ["http://europepmc.org/abstract/MED/21481795"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "TRK Inhibitor", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["FDA", "Other", "Other"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf", "http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"], "ref_urls": ["http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Bafetinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16105974"], "ref_urls": ["http://europepmc.org/abstract/MED/16105974"]}, {"gene_symbol": "ABL1", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["BOSUTINIB", "label/2012/203341lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=BOSUTINIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "ABL1", "therapy_name": "Rebastinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21481795"], "ref_urls": ["http://europepmc.org/abstract/MED/21481795"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "TRK Inhibitor", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "BCR", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["FDA"], "ref_ids": ["label/2012/203341lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "BCR", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}], "generated_rows": [{"variant_name": "ABL1 K356dup", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22713161"]}, {"variant_name": "ABL1 P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCL2L11 Alternative splicing", "gene_symbol": "BCL2L11", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["29100409"]}, {"variant_name": "BCL2L11 Deletion Polymorphism", "gene_symbol": "BCL2L11", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22426421"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D276G", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D363G", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16775234"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255K", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "15194504", "15930265"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E355G", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E459K", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E98G", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16775234"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317L", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "15930265"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["15930265", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F486S", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 G250E", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "12623848", "19075254", "15930265"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396R", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "15930265"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248V", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L364I", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16775234"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L384M", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16775234"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M244V", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "16775234"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M351T", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "16775234"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q252H", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 S417Y", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["20537386", "12623848", "15930265", "25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Y253F", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848", "15930265", "19075254"]}, {"variant_name": "KIT D816V", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16434489"]}, {"variant_name": "ABL1 Double Ph", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 A397P", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D276G", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255K", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19652056", "17264298", "15705718", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19652056", "17264298", "22371878", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E355G", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E453A", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E459K", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311L", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317L", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359C", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19652056", "17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359I", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19652056", "17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F486S", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 G250E", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396P", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396R", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248R", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["15705718", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248V", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L384M", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L387F", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M244V", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M351T", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 N336S", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q252H", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q300R", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 V299L", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 V379I", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298", "16772610"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Y253H", "gene_symbol": "BCR", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298", "22371878", "16772610"]}, {"variant_name": "ABL1 C475V", "gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}], "id": "F4.2-000047", "question": "For resistance to Imatinib in Chronic Myeloid Leukemia, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Imatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Imatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'chronic' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Imatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where toLower(t.name) = toLower('imatinib') OR toLower(t.name) CONTAINS toLower('imatinib') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('imatinib')).\n- Filter rel by effect = 'resistance' (case-insensitive).\n- Filter rel.disease_name by tokens 'chronic', 'myeloid', and 'leukemia' (case-insensitive CONTAINS for each token).\n- Return variant_name, gene_symbol, therapy_name, effect, disease_name, and rel.pmids (default [])."}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('non-small')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g2:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g2.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 1191.9797000009567, "input_tokens": 7264, "output_tokens": 236, "gold_rows": [{"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Brigatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571", "24675041"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "ALK S1206Y AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202del", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27432227"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK F1174C", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21030459"]}, {"variant_name": "ALK F1174V", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24736079"]}, {"variant_name": "ALK G1202R AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23729361"]}, {"variant_name": "ALK G1269A AND EML4::ALK e6::e19 AND ALK Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23434628"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393798", "24675041", "25228534"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "ALK L1152P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK L1198F", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ALK L1198P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21948233"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "21258415", "22912387"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK Amplification", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "23434628", "24675041", "22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1269A", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1152R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21791641"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "21948233"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e2::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18927303"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "KIF5B KIF5B::MET Fusion", "gene_symbol": "KIF5B", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29102694"]}, {"variant_name": "KRAS Amplification", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "KRAS G12V", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "MDM2 Amplification AND MET D1010H", "gene_symbol": "MDM2", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25898965"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}, {"variant_name": "MET D1010N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26892698"]}, {"variant_name": "MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442"]}, {"variant_name": "MET Exon 14 Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31932802", "31416808"]}, {"variant_name": "MET Exon 14 Skipping Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["35679833", "31584608", "123413", "26892698"]}, {"variant_name": "MET Exon 14 Skipping Mutation AND MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31055074"]}, {"variant_name": "MET MET::ATXN7L1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30339198"]}, {"variant_name": "NOT MET Amplification AND MET Exon 14 Skipping Mutation", "gene_symbol": "NOT", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27693535"]}, {"variant_name": "ROS1 G2032R", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157", "26372962"]}, {"variant_name": "ROS1 G2101A AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2155S AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 S1986F", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "27401242"]}, {"variant_name": "ROS1 S1986Y", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::NTRK3 Fusion", "gene_symbol": "EML4", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "NTRK3 G623R AND EML4::NTRK3 Fusion", "gene_symbol": "NTRK3", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "SQSTM1 SQSTM1::NTRK1 Fusion", "gene_symbol": "SQSTM1", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28183697"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30413378"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26554404"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ROS1 G2032R AND v::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 S1986Y/F", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "generated_rows": [{"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Brigatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571", "24675041"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "ALK S1206Y AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202del", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27432227"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK F1174C", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21030459"]}, {"variant_name": "ALK F1174V", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24736079"]}, {"variant_name": "ALK G1202R AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23729361"]}, {"variant_name": "ALK G1269A AND EML4::ALK e6::e19 AND ALK Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23434628"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393798", "24675041", "25228534"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "ALK L1152P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK L1198F", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ALK L1198P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21948233"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "21258415", "22912387"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK Amplification", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "23434628", "24675041", "22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1269A", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1152R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21791641"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "21948233"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e2::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18927303"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "KIF5B KIF5B::MET Fusion", "gene_symbol": "KIF5B", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29102694"]}, {"variant_name": "KRAS Amplification", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "KRAS G12V", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "MDM2 Amplification AND MET D1010H", "gene_symbol": "MDM2", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25898965"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}, {"variant_name": "MET D1010N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26892698"]}, {"variant_name": "MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442"]}, {"variant_name": "MET Exon 14 Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31932802", "31416808"]}, {"variant_name": "MET Exon 14 Skipping Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["35679833", "31584608", "123413", "26892698"]}, {"variant_name": "MET Exon 14 Skipping Mutation AND MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31055074"]}, {"variant_name": "MET MET::ATXN7L1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30339198"]}, {"variant_name": "NOT MET Amplification AND MET Exon 14 Skipping Mutation", "gene_symbol": "NOT", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27693535"]}, {"variant_name": "ROS1 G2032R", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157", "26372962"]}, {"variant_name": "ROS1 G2101A AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2155S AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 S1986F", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "27401242"]}, {"variant_name": "ROS1 S1986Y", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::NTRK3 Fusion", "gene_symbol": "EML4", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "NTRK3 G623R AND EML4::NTRK3 Fusion", "gene_symbol": "NTRK3", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "SQSTM1 SQSTM1::NTRK1 Fusion", "gene_symbol": "SQSTM1", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28183697"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30413378"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26554404"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ROS1 G2032R AND v::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 S1986Y/F", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "id": "F4.1-000033-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Non-small Cell Lung Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or synonyms match 'ALK' (case-insensitive).\n- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t).\n- Filter rel.disease_name to contain 'non-small', 'cell', 'lung', and 'carcinoma' (case-insensitive).\n- Return variant_name, gene_symbol, therapy_name, effect, disease_name, and rel.pmids."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('diffuse')\n  AND toLower(rel.disease_name) CONTAINS toLower('large')\n  AND toLower(rel.disease_name) CONTAINS toLower('b-cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('lymphoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 702.220400038641, "input_tokens": 7264, "output_tokens": 277, "gold_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}], "id": "F4.1-000047-P1", "question": "What drugs targeting ALK have biomarker evidence in Diffuse Large B-cell Lymphoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or synonyms match 'ALK' (case-insensitive).\n- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t).\n- Filter rel.disease_name to contain 'diffuse', 'large', 'b-cell', and 'lymphoma' (case-insensitive).\n- Return gene_symbol, therapy_name, effect, disease_name, and rel.pmids (default [])."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('stromal')\n  AND toLower(rel.disease_name) CONTAINS toLower('tumour')\n  AND toLower(rel.disease_name) CONTAINS toLower('gastrointestinal')\n  AND toLower(rel.disease_name) CONTAINS toLower('tract')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 648.8856000360101, "input_tokens": 7270, "output_tokens": 213, "gold_rows": [{"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Gastrointestinal Stromal Tumor", "pmids": ["40900786"]}], "generated_rows": [], "id": "F4.1-000072-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Stromal Tumour Of Gastrointestinal Tract.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'gastrointestinal' AND\n    toLower(rel.disease_name) CONTAINS 'stromal' AND\n    toLower(rel.disease_name) CONTAINS 'tumor'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or synonyms match 'ALK' (case-insensitive).\n- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t).\n- Filter rel.disease_name such that it CONTAINS 'stromal', 'tumour', 'gastrointestinal', and 'tract' (case-insensitive).\n- Return gene_symbol, therapy_name, effect, disease_name, and rel.pmids (default [])."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nOPTIONAL MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('glioblastoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n    CASE WHEN b IS NOT NULL AND b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    CASE WHEN rel IS NOT NULL THEN rel.effect ELSE NULL END AS effect,\n    CASE WHEN rel IS NOT NULL THEN rel.disease_name ELSE NULL END AS disease_name,\n    r.moa AS targets_moa,\n    coalesce(r.ref_sources, []) AS ref_sources,\n    coalesce(r.ref_ids, []) AS ref_ids,\n    coalesce(r.ref_urls, []) AS ref_urls,\n    CASE WHEN rel IS NOT NULL THEN coalesce(rel.pmids, []) ELSE [] END AS pmids\nLIMIT 100", "error": null, "latency_ms": 1175.1059000380337, "input_tokens": 7272, "output_tokens": 258, "gold_rows": [{"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ALK", "therapy_name": "ALK Inhibitor ASP3026", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["24419060"], "ref_urls": ["http://europepmc.org/abstract/MED/24419060"], "pmids": []}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2015/208434s000lbl.pdf", "nda/2015/208434Orig1s000ClinPharmR.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf"], "pmids": []}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Brigatinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.ariad.com/AP26113", "http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf", "25888090"], "ref_urls": ["http://europepmc.org/abstract/MED/25888090", "http://www.ariad.com/AP26113", "http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"], "pmids": []}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2014/205755s000lbl.pdf", "label/2017/205755s009lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"], "pmids": []}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"], "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"], "pmids": ["22162573"]}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.xcovery.com/our-science/alk-inhibitor/", "25322323"], "ref_urls": ["http://europepmc.org/abstract/MED/25322323", "http://www.xcovery.com/our-science/alk-inhibitor/"], "pmids": []}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "ALK", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212725s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"], "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ALK", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212725s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"], "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK  inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2018/210868s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"], "pmids": ["30171048"]}], "id": "F4.1-000096", "question": "Which therapies target ALK and also have biomarker evidence in Glioblastoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or synonyms match 'ALK' (case-insensitive).\n- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t) where rel.disease_name contains 'glioblastoma' (case-insensitive).\n- Return gene_symbol, therapy_name, targets_moa, ref_sources, ref_ids, ref_urls from the TARGETS relationship and variant_name, effect, disease_name, pmids from the AFFECTS_RESPONSE_TO relationship."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('AKT1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('AKT1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('cancer')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    r.moa AS targets_moa,\n    coalesce(r.ref_sources, []) AS ref_sources,\n    coalesce(r.ref_ids, []) AS ref_ids,\n    coalesce(r.ref_urls, []) AS ref_urls,\n    CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 639.360300032422, "input_tokens": 7261, "output_tokens": 222, "gold_rows": [{"variant_name": "AKT1 F55Y", "gene_symbol": "AKT1", "therapy_name": "ARQ092", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["35440569"]}, {"variant_name": "AKT1 E17K", "gene_symbol": "AKT1", "therapy_name": "Akt Inhibitor MK2206", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["23888070"]}, {"variant_name": "AKT3 Overexpression", "gene_symbol": "AKT3", "therapy_name": "Akt Inhibitor MK2206", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["27297869"]}, {"variant_name": "PIK3CA E545K", "gene_symbol": "PIK3CA", "therapy_name": "Akt Inhibitor MK2206", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["23888070"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Akt Inhibitor MK2206", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["22180495"]}, {"variant_name": "AKT1 D323G", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["35440569"]}, {"variant_name": "AKT1 E17K", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "AKT1 E17K", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["33377972"]}, {"variant_name": "AKT1 E17K", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["26351323"]}, {"variant_name": "AKT1 F55Y", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["35440569"]}, {"variant_name": "AKT1 L52R", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Endometrial Cancer", "pmids": ["35440569"]}, {"variant_name": "AKT1 P68-C77dup", "gene_symbol": "AKT1", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["35440569"]}, {"variant_name": "AKT2 L78_Q79ins", "gene_symbol": "AKT2", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Prostate Cancer", "pmids": ["35440569"]}, {"variant_name": "IRS2 Amplification", "gene_symbol": "IRS2", "therapy_name": "Capivasertib", "effect": "resistance", "disease_name": "Prostate Cancer", "pmids": ["35440569"]}, {"variant_name": "PIK3CA C420R", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA E542K", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA E542K AND PTEN Loss", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}, {"variant_name": "PIK3CA E545A", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA E545D", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA E545G", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA E545K", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA G1049R", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22294718"]}, {"variant_name": "PIK3CA H1047Y", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA M1043I", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA M1043V", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["28489509", "22294718"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22294718"]}, {"variant_name": "PIK3CA Mutation OR PTEN Mutation OR AKT1 Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA N345K", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA Q546E", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA Q546P", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["22294718"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Capivasertib", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Ipatasertib", "effect": "sensitivity", "disease_name": "Prostate Cancer", "pmids": ["34246347"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Ipatasertib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["23287563"]}, {"variant_name": "ZNF217 Overexpression", "gene_symbol": "ZNF217", "therapy_name": "Triciribine", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["22728437"]}], "generated_rows": [{"gene_symbol": "AKT1", "therapy_name": "ARQ092", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://files.shareholder.com/downloads/ARQL/0x0x520085/a3db887d-f50a-4736-919c-650d355b5d16/ARQ_092_AACR_poster_FINAL.PDF", "26469692"], "ref_urls": ["http://europepmc.org/abstract/MED/26469692", "http://files.shareholder.com/downloads/ARQL/0x0x520085/a3db887d-f50a-4736-919c-650d355b5d16/ARQ_092_AACR_poster_FINAL.PDF"], "variant_name": "AKT1 F55Y", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Akt Inhibitor MK2206", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "20571069"], "ref_urls": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "http://europepmc.org/abstract/MED/20571069"], "variant_name": "AKT1 E17K", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["23888070"]}, {"gene_symbol": "AKT1", "therapy_name": "Akt Inhibitor MK2206", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "20571069"], "ref_urls": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "http://europepmc.org/abstract/MED/20571069"], "variant_name": "AKT3 Overexpression", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["27297869"]}, {"gene_symbol": "AKT1", "therapy_name": "Akt Inhibitor MK2206", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "20571069"], "ref_urls": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "http://europepmc.org/abstract/MED/20571069"], "variant_name": "PIK3CA E545K", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["23888070"]}, {"gene_symbol": "AKT1", "therapy_name": "Akt Inhibitor MK2206", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "20571069"], "ref_urls": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract", "http://europepmc.org/abstract/MED/20571069"], "variant_name": "PIK3CA H1047R", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["22180495"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 D323G", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 E17K", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 E17K", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["33377972"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 E17K", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["26351323"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 F55Y", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 L52R", "effect": "sensitivity", "disease_name": "Endometrial Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT1 P68-C77dup", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "AKT2 L78_Q79ins", "effect": "sensitivity", "disease_name": "Prostate Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "IRS2 Amplification", "effect": "resistance", "disease_name": "Prostate Cancer", "pmids": ["35440569"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA C420R", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E542K", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E542K AND PTEN Loss", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E545A", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E545D", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E545G", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E545K", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA E545Q", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA G1049R", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA H1047L", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA H1047R", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA H1047R", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22294718"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA H1047Y", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA M1043I", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA M1043V", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Mutation", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["28489509", "22294718"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Mutation", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Mutation", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22294718"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Mutation OR PTEN Mutation OR AKT1 Mutation", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA N345K", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Q546E", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Q546K", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA Q546P", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PIK3CA R88Q", "effect": "sensitivity", "disease_name": "Her2-receptor Negative Breast Cancer", "pmids": ["37256976"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PTEN Loss", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["22294718"]}, {"gene_symbol": "AKT1", "therapy_name": "Capivasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"], "variant_name": "PTEN Loss", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}, {"gene_symbol": "AKT1", "therapy_name": "Ipatasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["22934575", "23287563"], "ref_urls": ["http://europepmc.org/abstract/MED/22934575", "http://europepmc.org/abstract/MED/23287563"], "variant_name": "PTEN Loss", "effect": "sensitivity", "disease_name": "Prostate Cancer", "pmids": ["34246347"]}, {"gene_symbol": "AKT1", "therapy_name": "Ipatasertib", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["22934575", "23287563"], "ref_urls": ["http://europepmc.org/abstract/MED/22934575", "http://europepmc.org/abstract/MED/23287563"], "variant_name": "PTEN Mutation", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["23287563"]}, {"gene_symbol": "AKT1", "therapy_name": "Triciribine", "targets_moa": "Serine/threonine-protein kinase AKT inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["15231645", "19422047"], "ref_urls": ["http://europepmc.org/abstract/MED/15231645", "http://europepmc.org/abstract/MED/19422047"], "variant_name": "ZNF217 Overexpression", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["22728437"]}], "id": "F4.1-000117-P3", "question": "Show treatments hitting AKT1 that have biomarker evidence in Cancer.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('AKT1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('AKT1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (t:Therapy)-[:TARGETS]->(g:Gene) where g.symbol or synonyms match 'AKT1' (case-insensitive).\n- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t).\n- Filter rel.disease_name to contain 'cancer' (case-insensitive).\n- Return gene_symbol, therapy_name, targets_moa, ref_sources, ref_ids, ref_urls, variant_name, effect, disease_name, and pmids."}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (\n    toLower(g.symbol) = toLower('SMARCB1')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('SMARCB1'))\n  )\n  AND toLower(b.name) CONTAINS toLower('Deletion')\nMATCH (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Tazemetostat')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tazemetostat'))\n    OR toLower(t.name) CONTAINS toLower('Tazemetostat')\n  )\n  AND toLower(rel.disease_name) CONTAINS toLower('epithelioid')\n  AND toLower(rel.disease_name) CONTAINS toLower('sarcoma')\nRETURN\n  b.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 635.8812999678776, "input_tokens": 7309, "output_tokens": 249, "gold_rows": [{"variant_name": "SMARCB1 Deletion", "gene_symbol": "SMARCB1", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Epithelioid Sarcoma", "pmids": ["33035459"]}], "generated_rows": [{"variant_name": "SMARCB1 Deletion", "gene_symbol": "SMARCB1", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Epithelioid Sarcoma", "pmids": ["33035459"]}], "id": "F2.2-000116-P3", "question": "How does SMARCB1 Deletion influence response to Tazemetostat for Epithelioid Sarcoma?", "gold_cypher": "MATCH (v:Variant {name: 'SMARCB1 Deletion'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Tazemetostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tazemetostat'))\n  OR toLower(t.name) CONTAINS toLower('Tazemetostat')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'epithelioid' AND\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (b:Variant)-[:VARIANT_OF]->(g:Gene) where g.symbol is 'SMARCB1' (or a synonym) and toLower(b.name) CONTAINS toLower('Deletion').\n- Match (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where t.name is 'Tazemetostat' (or a synonym or contains).\n- Match toLower(rel.disease_name) CONTAINS toLower('epithelioid') AND toLower(rel.disease_name) CONTAINS toLower('sarcoma').\n- Return variant_name, gene_symbol, therapy_name, effect, disease_name, and rel.pmids."}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Everolimus')\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Everolimus'))\n    OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nWITH b, rel, t\nWHERE b:Variant\nAND toLower(b.name) CONTAINS toLower('RPS6 PHOSPHORYLATION')\nWITH b, rel, t\nMATCH (b)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\n  AND toLower(rel.disease_name) CONTAINS toLower('stomach')\nRETURN\n  b.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 1174.5073999627493, "input_tokens": 7317, "output_tokens": 227, "gold_rows": [{"variant_name": "RPS6 PHOSPHORYLATION", "gene_symbol": "RPS6", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Gastric Adenocarcinoma", "pmids": ["22343617"]}], "generated_rows": [], "id": "F2.2-000185-S1", "question": "How does the variant RPS6 PHOSPHORYLATION affect response to Everolimus in Adenocarcinoma Of Stomach?", "gold_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "instructions": "- Match (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy) where t.name (or synonyms) case-insensitively matches 'Everolimus'.\n- Match (b:Biomarker) where b is a Variant with name case-insensitively containing 'RPS6 PHOSPHORYLATION'.\n- Match (b:Biomarker)-[:VARIANT_OF]->(g:Gene).\n- Match rel.disease_name where it case-insensitively contains 'adenocarcinoma', 'stomach'.\n- Return variant_name, gene_symbol, therapy_name, effect, disease_name, and rel.pmids (defaulting to [] if absent)."}
